ModernMedicine Resource Center More Topics

Idiopathic Pulmonary Fibrosis Resource Center

Effective diagnostic methods for IPF
Effective diagnostic methods for IPFHigh-resolution computed tomography (HRCT) scans have quickly become the most effective tool for firmly diagnosing idiopathic pulmonary fibrosis (IPF).
New protein linked to IPF severity and survival
New protein linked to IPF severity and survivalA groundbreaking new genetic discovery could lead to future pharmaceutical therapies to treat the rare condition, idiopathic pulmonary fibrosis (IPF).
PFF expands patient registry and care center network
PFF expands patient registry and care center networkThe Pulmonary Fibrosis Foundation is expanding its Patient Care Network and Patient Registry, which it formed in late 2013 to improve the quality of life for patients with all types of pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF).
Pirfenidone reduces disease progression of IPF
Pirfenidone reduces disease progression of IPFPirfenidone (Esbriet), an oral antifibrotic therapy, was able to reduce progression of idiopathic pulmonary fibrosis (IPF) and reduce the risk of mortality, according to phase 3 trial results presented at the American Thoracic Society International Conference in San Diego.
Investigational TKI nintedanib slowed lung function loss in idiopathic pulmonary fibrosis
Investigational TKI nintedanib slowed lung function loss in idiopathic pulmonary fibrosisNintedanib, an investigational small molecule tyrosine kinase inhibitor (TKI), slowed lung function loss in patients with idiopathic pulmonary fibrosis (IPF), according to the results of 2 pivotal phase 3 trials presented at the American Thoracic Society International Conference in San Diego.